These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20496925)

  • 41. Visualization of HIV-1 Gag Binding to Giant Unilamellar Vesicle (GUV) Membranes.
    Olety B; Veatch SL; Ono A
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain.
    Dalton AK; Ako-Adjei D; Murray PS; Murray D; Vogt VM
    J Virol; 2007 Jun; 81(12):6434-45. PubMed ID: 17392361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.
    Nadaraia-Hoke S; Bann DV; Lochmann TL; Gudleski-O'Regan N; Parent LJ
    J Virol; 2013 Mar; 87(6):3609-15. PubMed ID: 23325682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.
    Chan J; Dick RA; Vogt VM
    J Virol; 2011 Oct; 85(20):10851-60. PubMed ID: 21813603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy.
    Stephen AG; Datta SA; Worthy KM; Bindu L; Fivash MJ; Turner KB; Fabris D; Rein A; Fisher RJ
    J Biomol Tech; 2007 Sep; 18(4):259-66. PubMed ID: 17916799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ceramide-1-phosphate transfer protein (CPTP) regulation by phosphoinositides.
    Gao YG; Zhai X; Boldyrev IA; Molotkovsky JG; Patel DJ; Malinina L; Brown RE
    J Biol Chem; 2021; 296():100600. PubMed ID: 33781749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of HIV-1 Gag with assembly cofactors.
    Shkriabai N; Datta SA; Zhao Z; Hess S; Rein A; Kvaratskhelia M
    Biochemistry; 2006 Apr; 45(13):4077-83. PubMed ID: 16566581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting of murine leukemia virus gag to the plasma membrane is mediated by PI(4,5)P2/PS and a polybasic region in the matrix.
    Hamard-Peron E; Juillard F; Saad JS; Roy C; Roingeard P; Summers MF; Darlix JL; Picart C; Muriaux D
    J Virol; 2010 Jan; 84(1):503-15. PubMed ID: 19828619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanistic Investigation of HIV-1 Gag Association with Lipid Membranes.
    Tran RJ; Lalonde MS; Sly KL; Conboy JC
    J Phys Chem B; 2019 Jun; 123(22):4673-4687. PubMed ID: 31084006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of phosphoinositides reveals strong enrichment of PIP
    Mücksch F; Citir M; Lüchtenborg C; Glass B; Traynor-Kaplan A; Schultz C; Brügger B; Kräusslich HG
    Sci Rep; 2019 Nov; 9(1):17661. PubMed ID: 31776383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural and molecular determinants of HIV-1 Gag binding to the plasma membrane.
    Vlach J; Saad JS
    Front Microbiol; 2015; 6():232. PubMed ID: 25852680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides.
    Chan R; Uchil PD; Jin J; Shui G; Ott DE; Mothes W; Wenk MR
    J Virol; 2008 Nov; 82(22):11228-38. PubMed ID: 18799574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV-1 Gag specificity for PIP
    Socas LBP; Ambroggio EE
    Biochim Biophys Acta Biomembr; 2023 Jun; 1865(5):184157. PubMed ID: 37028700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of New L-Heptanoylphosphatidyl Inositol Pentakisphosphate Derivatives Targeting the Interaction with HIV-1 Gag by Molecular Modelling Studies.
    Ciftci H; Sever B; Ayan E; Can M; DeMirci H; Otsuka M; TuYuN AF; Tateishi H; Fujita M
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell Permeable Ratiometric Fluorescent Sensors for Imaging Phosphoinositides.
    Mondal S; Rakshit A; Pal S; Datta A
    ACS Chem Biol; 2016 Jul; 11(7):1834-43. PubMed ID: 27082310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Method for estimating the single molecular affinity.
    Schasfoort RB; Lau Wd; Kooi Av; Clevers H; Engbers GH
    Anal Biochem; 2012 Feb; 421(2):794-6. PubMed ID: 22209736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure of the myristylated human immunodeficiency virus type 2 matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in membrane targeting.
    Saad JS; Ablan SD; Ghanam RH; Kim A; Andrews K; Nagashima K; Soheilian F; Freed EO; Summers MF
    J Mol Biol; 2008 Oct; 382(2):434-47. PubMed ID: 18657545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphoinositide-containing polymerized liposomes: stable membrane-mimetic vesicles for protein-lipid binding analysis.
    Ferguson CG; James RD; Bigman CS; Shepard DA; Abdiche Y; Katsamba PS; Myszka DG; Prestwich GD
    Bioconjug Chem; 2005; 16(6):1475-83. PubMed ID: 16287244
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Membrane association of the PTEN tumor suppressor: molecular details of the protein-membrane complex from SPR binding studies and neutron reflection.
    Shenoy S; Shekhar P; Heinrich F; Daou MC; Gericke A; Ross AH; Lösche M
    PLoS One; 2012; 7(4):e32591. PubMed ID: 22505997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphate number and acyl chain length determine the subcellular location and lateral mobility of phosphoinositides.
    Cho H; Kim YA; Ho WK
    Mol Cells; 2006 Aug; 22(1):97-103. PubMed ID: 16951556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.